Human leukocyte antigen - DR beta chain presenting tetanus toxoid-derived peptide TT830-844 (HLA-DRB/TT830-844)

The Human leukocyte antigen - DR beta chain (HLA-DRB) presenting the TT830-844 tetanus toxoid-derived CD4+ T-cell epitope is a molecular complex essential for the activation of the adaptive immune system. The TT830-844 peptide (sequence: QYIKANSKFIGITEL), derived from the tetanus toxin, is recognized as a "universal" or "promiscuous" T-cell epitope because of its ability to bind to a wide range of HLA-DR alleles across diverse human populations (Panina-Bordignon et al., 1989, European Journal of Immunology). This complex is formed when antigen-presenting cells process the tetanus toxoid and display the peptide on their surface via Major Histocompatibility Complex (MHC) Class II molecules. Recognition of this complex by the T-cell receptor (TCR) on CD4+ T cells is a critical step in generating a robust immune response, including the provision of "help" for B-cell antibody production and CD8+ T-cell activation (Demotz et al., 1989, Science). In clinical and research settings, this epitope is frequently utilized as a potent adjuvant in peptide vaccines to enhance immunogenicity or as a positive control in assays measuring T-cell function (Valmori et al., 1992, Journal of Immunology). Its role in disease is primarily associated with protective immunity against Clostridium tetani, though its universal binding properties make it a valuable tool in developing therapies for cancer and infectious diseases. The complex is a target for novel immunotherapies, including TCR-like antibodies and engineered T-cells designed to exploit the high frequency of TT-specific memory T cells in the general population.

Other names

MHC Class II-TT830-844 complexHLA-DR/TT830-844Tetanus toxoid epitope 830-844/HLA-DRB complexUniversal T-cell epitope TT830-844P2 epitopeHLA-DRB presenting the TT830-844 tetanus toxoid-derived CD4+ T-cell epitope

The complex acts as a ligand for the T-cell receptor (TCR) on CD4+ T helper cells, triggering signal transduction that leads to cytokine production and immune system orchestration.